|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dubrow R, Darefsky AS, Jacobs DI, Park LS,
Rose MG, Laurans MS and King JT Jr: Time trends in glioblastoma
multiforme survival: The role of temozolomide. Neuro-oncol.
15:1750–1761. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Alexiou GA, Tsiouris S, Kyritsis AP,
Voulgaris S, Argyropoulou MI and Fotopoulos AD: Glioma recurrence
versus radiation necrosis: Accuracy of current imaging modalities.
J Neurooncol. 95:1–11. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cooper LA, Gutman DA, Chisolm C, Appin C,
Kong J, Rong Y, Kurc T, Van Meir EG, Saltz JH, Moreno CS, et al:
The tumor microenvironment strongly impacts master transcriptional
regulators and gene expression class of glioblastoma. Am J Pathol.
180:2108–2119. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Galon J, Pagès F, Marincola FM, Thurin M,
Trinchieri G, Fox BA, Gajewski TF and Ascierto PA: The immune score
as a new possible approach for the classification of cancer. J
Transl Med. 10(1)2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M,
Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A,
et al: Tumor immune microenvironment characterization in clear cell
renal cell carcinoma identifies prognostic and
immunotherapeutically relevant messenger RNA signatures. Genome
Biol. 17(231)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chang N, Ahn SH, Kong DS, Lee HW and Nam
DH: The role of STAT3 in glioblastoma progression through dual
influences on tumor cells and the immune microenvironment. Mol Cell
Endocrinol. 451:53–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang B, Shen R, Cheng S and Feng L:
Immune microenvironments differ in immune characteristics and
outcome of glioblastoma multiforme. Cancer Med. 8:2897–2907.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jia D, Li S, Li D, Xue H, Yang D and Liu
Y: Mining TCGA database for genes of prognostic value in
glioblastoma microenvironment. Aging (Albany NY). 10:592–605.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Akimoto K, Kimura K, Nagano M, Takano S,
To'a Salazar G, Yamashita T and Ohneda O: Umbilical cord
blood-derived mesenchymal stem cells inhibit, but adipose
tissue-derived mesenchymal stem cells promote, glioblastoma
multiforme proliferation. Stem Cells Dev. 22:1370–1386.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Boonstra MC, Verbeek FP, Mazar AP, Prevoo
HA, Kuppen PJ, van de Velde CJ, Vahrmeijer AL and Sier CF:
Expression of uPAR in tumor-associated stromal cells is associated
with colorectal cancer patient prognosis: A TMA study. BMC Cancer.
14(269)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Miki Y, Yashiro M, Okuno T, Kuroda K,
Togano S, Hirakawa K and Ohira M: Clinico-pathological significance
of exosome marker CD63 expression on cancer cells and stromal cells
in gastric cancer. PLoS One. 13(e0202956)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun.
4(2612)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lambert SA, Jolma A, Campitelli LF, Das
PK, Yin Y, Albu M, Chen X, Taipale J, Hughes TR and Weirauch MT:
The Human Transcription Factors. Cell. 172:650–665. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Malysheva V, Mendoza-Parra MA, Saleem MA
and Gronemeyer H: Reconstruction of gene regulatory networks
reveals chromatin remodelers and key transcription factors in
tumorigenesis. Genome Med. 8(57)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang Q, Hu B, Hu X, Kim H, Squatrito M,
Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, et al: Tumor
Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates
with Immunological Changes in the Microenvironment. Cancer Cell.
32:42–56.e6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chong YK, Sandanaraj E, Koh LW,
Thangaveloo M, Tan MS, Koh GR, Toh TB, Lim GG, Holbrook JD, Kon OL,
et al: ST3GAL1-Associated Transcriptomic Program in Glioblastoma
Tumor Growth, Invasion, and Prognosis. J Natl Cancer Inst.
108(djv326)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yan ZH, Bao ZS, Yan W, Liu YW, Zhang CB,
Wang HJ, Feng Y, Wang YZ, Zhang W, You G, et al: Upregulation of
DLX2 confers a poor prognosis in glioblastoma patients by inducing
a proliferative phenotype. Curr Mol Med. 13:438–445.
2013.PubMed/NCBI
|
|
20
|
Wang S, Liu F, Wang Y, Fan W, Zhao H, Liu
L, Cen C, Jiang X, Sun M and Han P: Integrated analysis of 34
microarray datasets reveals CBX3 as a diagnostic and prognostic
biomarker in glioblastoma. J Transl Med. 17(179)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets - update. Nucleic Acids Res. 41D:D991–D995.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: limma: Linear models for microarray data In:
Bioinformatics and Computational Biology Solutions Using R and
Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry RA and
Dudoit S (eds). Springer, New York, NY, pp397-420, 2005.
|
|
23
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee KJ and Simpson JA: Introduction to
multiple imputation for dealing with missing data. Respirology.
19:162–167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rummel PC, Thiele S, Hansen LS, Petersen
TP, Sparre-Ulrich AH, Ulven T and Rosenkilde MM: Extracellular
disulfide bridges serve different purposes in two homologous
chemokine receptors, CCR1 and CCR5. Mol Pharmacol. 84:335–345.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cobaleda C, Pérez-Caro M, Vicente-Dueñas C
and Sánchez-García I: Function of the zinc-finger transcription
factor SNAI2 in cancer and development. Annu Rev Genet. 41:41–61.
2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yi L, Zhou X, Li T, Liu P, Hai L, Tong L,
Ma H, Tao Z, Xie Y, Zhang C, et al: Notch1 signaling pathway
promotes invasion, self-renewal and growth of glioma initiating
cells via modulating chemokine system CXCL12/CXCR4. J Exp Clin
Cancer Res. 38(339)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC,
Jiang T, Lin MC, Chen JH, Wang B, Zhang R, et al: The chemokine
CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated
VEGF production and tumour angiogenesis via PI3K/AKT signalling. J
Pathol. 224:344–354. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu Y, Wei S, Zou Q and Luo Y: Stachydrine
suppresses viability & migration of astrocytoma cells via
CXCR4/ERK & CXCR4/Akt pathway activity. Future Oncol.
14:1443–1459. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cheng Q, Huang C, Cao H, Lin J, Gong X, Li
J, Chen Y, Tian Z, Fang Z and Huang J: A Novel Prognostic Signature
of Transcription Factors for the Prediction in Patients With GBM.
Front Genet. 10(906)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liao H, Bai Y, Qiu S, Zheng L, Huang L,
Liu T, Wang X, Liu Y, Xu N, Yan X, et al: miR-203 downregulation is
responsible for chemoresistance in human glioblastoma by promoting
epithelial-mesenchymal transition via SNAI2. Oncotarget.
6:8914–8928. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fenouille N, Tichet M, Dufies M, Pottier
A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari
A, et al: The epithelial-mesenchymal transition (EMT) regulatory
factor SLUG (SNAI2) is a downstream target of SPARC and AKT in
promoting melanoma cell invasion. PLoS One.
7(e40378)2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Laakkonen JP, Lappalainen JP, Theelen TL,
Toivanen PI, Nieminen T, Jauhiainen S, Kaikkonen MU, Sluimer JC and
Ylä-Herttuala S: Differential regulation of angiogenic cellular
processes and claudin-5 by histamine and VEGF via PI3K-signaling,
transcription factor SNAI2 and interleukin-8. Angiogenesis.
20:109–124. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Huasong G, Zongmei D, Jianfeng H, Xiaojun
Q, Jun G, Sun G, Donglin W and Jianhong Z: Serine protease
inhibitor (SERPIN) B1 suppresses cell migration and invasion in
glioma cells. Brain Res. 1600:59–69. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Miyauchi E, Furuta T, Ohtsuki S, Tachikawa
M, Uchida Y, Sabit H, Obuchi W, Baba T, Watanabe M, Terasaki T, et
al: Identification of blood biomarkers in glioblastoma by SWATH
mass spectrometry and quantitative targeted absolute proteomics.
PLoS One. 13(e0193799)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Li Y, Dong X, Cai J, Yin S, Sun Y, Yang D
and Jiang C: SERPINA3 induced by astroglia/microglia co-culture
facilitates glioblastoma stem-like cell invasion. Oncol Lett.
15:285–291. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ding Z, Liu X, Liu Y, Zhang J, Huang X,
Yang X, Yao L, Cui G and Wang D: Expression of far upstream element
(FUSE) binding protein 1 in human glioma is correlated with c-Myc
and cell proliferation. Mol Carcinog. 54:405–415. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen H, Guo Y, Sun J, Dong J, Bao Q, Zhang
X and Fu F: Preferential Expression of B7-H6 in Glioma Stem-Like
Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis. J
Immunol Res. 2020(2328675)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Eiraku Y, Terunuma H, Yagi M, Deng X,
Nicol AJ and Nieda M: Dendritic cells cross-talk with tumour
antigen-specific CD8+ T cells, Vγ9γδT cells and Vα24NKT
cells in patients with glioblastoma multiforme and in healthy
donors. Clin Exp Immunol. 194:54–66. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Prasad S, Gaedicke S, Machein M, Mittler
G, Braun F, Hettich M, Firat E, Klingner K, Schüler J, Wider D, et
al: Effective Eradication of Glioblastoma Stem Cells by Local
Application of an AC133/CD133-Specific T-cell-Engaging Antibody and
CD8 T Cells. Cancer Res. 75:2166–2176. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Xu X, Stockhammer F, Schmitt A,
Casalegno-Garduno R, Enders A, Mani J, Classen CF, Linnebacher M,
Freund M and Schmitt M: Therapeutical doses of temozolomide do not
impair the function of dendritic cells and CD8+ T cells.
Int J Oncol. 40:764–772. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pellegatta S, Poliani PL, Stucchi E, Corno
D, Colombo CA, Orzan F, Ravanini M and Finocchiaro G: Intra-tumoral
dendritic cells increase efficacy of peripheral vaccination by
modulation of glioma microenvironment. Neuro-oncol. 12:377–388.
2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Candolfi M, King GD, Yagiz K, Curtin JF,
Mineharu Y, Muhammad AK, Foulad D, Kroeger KM, Barnett N, Josien R,
et al: Plasmacytoid dendritic cells in the tumor microenvironment:
Immune targets for glioma therapeutics. Neoplasia. 14:757–770.
2012.PubMed/NCBI View Article : Google Scholar
|
